European Journal of Health Economics

Article	Citations
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19	699
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines	148
Historical evidence for economic effects of COVID-19	137
Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues	90
COVID-19 and income inequality in OECD countries	84
Cost and effects of integrated care: a systematic literature review and meta-analysis	79
Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe	50
Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy	43
The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes	39
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies	37
An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values	36
Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life	34
The economic burden of obesity in Italy: a cost-of-illness study	34
More room for telemedicine after COVID-19: lessons for primary care?	33
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies	32
COVID-19 and the role of inequality in French regional departments	30
How expensive are post-traumatic stress disorders? Estimating incremental health care and economic costs on anonymised claims data	26
Health effects from heat waves in France: an economic evaluation	26
EQ-5D-5L Bulgarian population norms	25
Efficiency and productivity of health systems in prevention and control of non-communicable diseases in China, 2008–2015	23
Modelling Covid-19 under uncertainty: what can we expect?	23
The “red herring” after 20 years: ageing and health care expenditures	23
Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states	22
The remarkably frequent use of EQ-5D in non-economic research	22
Discrete choice experiments to generate utility values for multi-attribute utility instruments: a systematic review of methods	21

General population normative data for the EQ-5D-3L in the five largest European economies	21
Impacts of air pollution on health: evidence from longitudinal cohort data of patients with cardiovascular diseases	21
Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan	21
Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A	19
The impact of the great economic crisis on mental health care in Italy	19
Does the universal medical insurance system reduce catastrophic health expenditure among middle-aged and elderly households in China? A longitudinal analysis	19
The effect of long-term care public benefits and insurance on informal care from outside the household: empirical evidence from Italy and Spain	19
Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies	18
Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana	18
Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia	18
What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev	17
Economics of mental well-being: a prospective study estimating associated health care costs and sickness benefit transfers in Denmark	17
The excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria	17
Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression	16
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018	16
Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations	16
Health state utility values by cancer stage: a systematic literature review	16
The relationship between renewable energy use and health expenditures in EU countries	16
Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections	15
Patient-caregiver agreement and test–retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies	15
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)	15
Economic analysis of open versus laparoscopic versus robotic hepatectomy: a systematic review and meta-analysis	15
Predictors of negotiated prices for new drugs in Germany	15
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerl	14
Health-related quality of life in elderly people with hypertension and the estimation of minimally important difference using EQ-5D-5L in Hong Kong SAR, China	14
The Italian NHS at regional level: same in theory, different in practice	14
The impact of COVID-19 pandemic on insurance demand: the case of China	14
Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China	13
Very high and low residual spenders in private health insurance markets: Germany, The Netherlands and the U.S. Marketplaces	13
The impact of social health insurance on rural populations	13
The economic burden of amyotrophic lateral sclerosis: a systematic review	13
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland	13
Machine learning versus regression modelling in predicting individual healthcare costs from a representative sample of the nationwide claims database in France	13
Do European pharmacists really have to trespass on medicine?	13
Comparison of the three-level and the five-level versions of the EQ-5D	13
Does socioeconomic status affect hospital utilization and health outcomes of chronic disease patients?	12
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions	12
Income and conversion handicaps: estimating the impact of child chronic illness/disability on family income and the extra cost of child chronic illness/child disability in Ireland using a standard of	12
The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study	12
COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach	11
Has the development of cancer biomarkers to guide treatment improved health outcomes?	11
Work ethics, stay-at-home measures and COVID-19 diffusion	11
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges	11
Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries	11
Income level and antibiotic misuse: a systematic review and dose–response meta-analysis	11
The effect of mental and physical health problems on sickness absence	11
Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening	11
Should health technology assessment be more patient centric? If so, how?	11
Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment	10
Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data	10

‘Relative Consent’ or ‘Presumed Consent’? Organ donation attitudes and behaviour	10
Estimating the monetary value of health and capability well-being applying the well-being valuation approach	10
EQ-5D-5L Portuguese population norms	10
Value drivers of development stage biopharma companies	10
The economics of alternative payment models for pharmaceuticals	10
The causal impact of sugar taxes on soft drink sales: evidence from France and Hungary	10
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	10
Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region	10
The effect of alcohol tax changes on retail prices: how do on-trade alcohol retailers pass through tax changes to consumers?	10
Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in Ethiopia	10
Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting	10
The impact of the diabetes management incentive on diabetes-related services: evidence from Ontario, Canada	9
The impact of decentralisation on the performance of health care systems: a non-linear relationship	9
General practitioners’ income and activity: the impact of multi-professional group practice in France	9
Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland	9
Voluntary private health insurance, health-related behaviours and health outcomes: evidence from Russia	9
The residential healthcare for the elderly in Italy: some considerations for post-COVID-19 policies	9
Were we happy and we didn’t know it? A subjective dynamic and financial assessment pre-, during and post-COVID-19	9
The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies	9
Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas	9
Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain	9
Quantifying the economic impact of caregiving for Duchenne muscular dystrophy (DMD) in Spain	9
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction	9
Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis	8
Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups	8
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease	8
The impact of nurse staffing levels on nursing-sensitive patient outcomes: a multilevel regression approach	8
Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China	8
Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists	8
Willingness-to-pay for cancer treatment and outcome: a systematic review	8
Business cycle and mortality in Spain	8
Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home: a systematic review	8
Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy	8
Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations	8
The association between bed occupancy rates and hospital quality in the English National Health Service	8
Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique	8
Economic and social cost of epilepsy in Poland: 5-year analysis	8
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic	7
Can drones save lives and money? An economic evaluation of airborne delivery of automated external defibrillators	7
Costs and management of patients with hemophilia A in France: the Hemraude study	7
The cost-effectiveness of unilateral cochlear implants in UK adults	7
Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis	7
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations	7
Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above	7
The effects of patient cost-sharing on health expenditure and health among older people: Heterogeneity across income groups	7
How French general practitioners respond to declining medical density: a study on prescription practices, with an insight into opioids use	7
Consideration of quality of life in the health technology assessments of rare disease treatments	7
The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study	6
Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients	6
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy	6
Effects of establishing a financing scheme for outpatient care on inpatient services: empirical evidence from a quasi-experiment in China	6
Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study	6
The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups	6
Canada population norms for the EQ-5D-5L	6
Lifetime cost of unilateral cochlear implants in adults: a Monte Carlo simulation	6
Does voluntary health insurance improve health and longevity? Evidence from European OECD countries	6
Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities	6
Investigating the geographic disparity in quality of care: the case of hospital readmission after acute myocardial infarction in Italy	6
Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014	6
Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries	6
Regional medical practice variation in high-cost healthcare services	6
Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets	6
Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome	6
Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany	6
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation	6
European union regulation of health technology assessment: what is required for it to succeed?	6
Ageing and health care expenditures: the importance of age per se, steepening of the individual-level expenditure curve, and the role of morbidity	6
Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis	6
Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis	6
Communities and testing for COVID-19	6
Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology	6
Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment	5
Willingness to provide informal care to older adults in Germany: a discrete choice experiment	5
EQ-5D-5L: a value set for Romania	5
Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment	5
Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits	5
Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands	5
Financial risk allocation and provider incentives in hospital–insurer contracts in The Netherlands	5
Multi-layer health insurance coverage, medical services use and health in a Universal National Health System, the case of Portugal	5
General practice in the EU: countries you see, customs you find	5

The goal of risk equalization in regulated competitive health insurance markets	5
Accreditation as a quality-improving policy tool: family planning, maternal health, and child health in Egypt	5
Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study	5
Does compulsory schooling affect health? Evidence from ambulatory claims data	5
Production losses due to mortality associated with modifiable health risk factors in Poland	5
Measuring the acceptability of EQ-5D-3L health states for different ages: a new adaptive survey methodology	5
The impact of taxing sugar-sweetened beverages on cola purchasing in Catalonia: an approach to causal inference with time series cross-sectional data	5
Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review	5
Multiplicative modelling of EQ-5D-3L TTO and VAS values	5
“The reputation premium”: does hospital ranking improvement lead to a higher healthcare spending?	4
COVID-19: not the time for health economists? A plea for more proactive health economic involvement	4
Risky business, healthy lives: how risk perception, risk preferences and information influence consumer’s risky health choices	4
Complexities of health and acceptance of electronic health records for the Austrian elderly population	4
A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots	4
Efficiency ratio and rocketing drug prices: old concerns and new possibilities	4
The contribution of resident physicians to hospital productivity	4
Awaiting the “catharsis”	4
The effect of time to death on health care expenditures: taking into account the endogeneity and right censoring of time to death	4
Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data	4
Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands	4
Population norms in France with EQ-5D-5L: health states, value indexes, and VAS	4
Retirement, social support and mental well-being: a couple-level analysis	4
Health measures and long-term care use in the European frail population	4
The impact of inpatient bed capacity on length of stay	4
The pass-through of excise taxes to market prices of heated tobacco products (HTPs) and cigarettes: a cross-country analysis	4
Mapping of head and neck cancer patient concerns inventory scores on to Euroqol-Five Dimensions-Five Levels (EQ-5D-5L) health utility scores	4
Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial	4
Using fees to reduce bed-blocking: a game between hospitals and long-term care providers	4
Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population	4
Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests	4
On the correlation between outcome indicators and the structure and process indicators used to proxy them in public health care reporting	4
Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment	4
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics	4
Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality	4
Estimating the additional costs of living with a disability in the United Kingdom between 2013 and 2016	4
Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary	4
Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition	4
Structural factors and integrated care interventions: is there a role for economists in the policy debate?	4
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design	4
Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates	4
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)	4
Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?	4
The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study	4
Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease	4
The role of income disparities on survival in metastatic clear cell renal cell carcinoma in the targeted therapy era	4
Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries	3
Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skele	3
Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme	3
Insurance coverage, long-term care utilization, and health outcomes	3
Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system	3
Do preferences differ based on respondent experience of a health issue and its treatment? A case study using a public health intervention	3
Online and offline health information seeking and the demand for physician services	3
A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway	3
Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries	3
Live and let live: understanding the temporal drivers and spillovers of life expectancy in Europe for public planning	3
Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders	3
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population	3
Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer	3
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms	3
Psychometric properties and general population reference values for PROMIS Global Health in Hungary	3
Public preferences for policies promoting a healthy diet: a discrete choice experiment	3
Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective	3
Discounting in economic evaluation of healthcare interventions: what about the risk term?	3
The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations	3
Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg)	3
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database	3
Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature	3
Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study	3
A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands	3
Does a working day keep the doctor away? A critical review of the impact of unemployment and job insecurity on health and social care utilisation	3
Informal care at old age at home and in nursing homes: determinants and economic value	3
Adoption of large-scale medical equipment: the impact of competition in the German inpatient sector	3
The attractiveness of jobs in the German care sector: results of a factorial survey	3
Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study	3
Lifetime direct healthcare costs of treating colorectal cancer: a systematic review	3
The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off	3
A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program	3
Accountability for an unhealthy lifestyle	3
Value appropriation in hepatitis C	2
Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients	2
Costing methodologies in European economic evaluation guidelines: commonalities and divergences	2
Significant healthcare burden and life cost of spinal muscular atrophy: real-world data	2
Obesity Kuznets curve and the reality of eco-income ellipsoids (EIE)	2
Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK	2
The cost of chemotherapy administration: a systematic review and meta-analysis	2
Catastrophic household expenditure associated with out-of-pocket payments for dental healthcare in Spain	2
Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective co	2
Does the amount of formal care affect informal care? Evidence among over-60s in France	2
Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland	2
Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly	2
Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality	2
Are long-term care jobs harmful? Evidence from Germany	2
Out-of-pocket costs sustained in the last 12 months by cancer patients: an Italian survey-based study on individual expenses between 2017 and 2018	2
Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system	2
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review	2